EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction: Nishimura et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut–Liver Axis and Epiregulin–IL-8-Associated Angiogenesis. Int. J. Mol. Sci. 2025, 26, 6710

Naoki Nishimura, Kosuke Kaji, Norihisa Nishimura iD, Junichi Hanatani iD, Tatsuya Nakatani iD, Masafumi Oyama, Akihiko Shibamoto, Yuki Tsuji, Koh Kitagawa iD, Shinya Sato iD, Tadashi Namisaki iD, Satoru Tamaoki und 1 weitere

International Journal of Molecular Sciences · 06.08.2026 · 27 (15) · 7041

DOI: 10.3390/ijms27157041 ↗

Kurz gefasst

Korrektur in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.08.2026. Verfasst von Naoki Nishimura und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the original publication [...]

Autor:innen und Institutionen

  • Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
  • Medical Affairs Department, ASKA Pharmaceutical Co., Ltd., Minato-ku 108-8532, Tokyo, Japan.

ORCID-Profile: Norihisa Nishimura, Junichi Hanatani, Tatsuya Nakatani, Koh Kitagawa, Shinya Sato, Tadashi Namisaki

Zitieren

APA

Nishimura, N., Kaji, K., Nishimura, N., Hanatani, J., Nakatani, T., Oyama, M., Shibamoto, A., Tsuji, Y., Kitagawa, K., Sato, S., Namisaki, T., Tamaoki, S., & Yoshiji, H. (2026). Correction: Nishimura et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut–Liver Axis and Epiregulin–IL-8-Associated Angiogenesis. Int. J. Mol. Sci. 2025, 26, 6710. International Journal of Molecular Sciences, 27(15), 7041. https://doi.org/10.3390/ijms27157041

Vancouver

Nishimura N, Kaji K, Nishimura N, Hanatani J, Nakatani T, Oyama M, et al. Correction: Nishimura et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut–Liver Axis and Epiregulin–IL-8-Associated Angiogenesis. Int. J. Mol. Sci. 2025, 26, 6710. International Journal of Molecular Sciences. 2026;27(15):7041. doi:10.3390/ijms27157041

BibTeX
@article{Nishimura2026,
  author = {Nishimura, Naoki and Kaji, Kosuke and Nishimura, Norihisa and Hanatani, Junichi and Nakatani, Tatsuya and Oyama, Masafumi and Shibamoto, Akihiko and Tsuji, Yuki and Kitagawa, Koh and Sato, Shinya and Namisaki, Tadashi and Tamaoki, Satoru and Yoshiji, Hitoshi},
  title = {Correction: Nishimura et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut–Liver Axis and Epiregulin–IL-8-Associated Angiogenesis. Int. J. Mol. Sci. 2025, 26, 6710},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {15},
  pages = {7041},
  doi = {10.3390/ijms27157041}
}
Kostenlos starten →